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Abstract
Introduction: Fibro-osseous lesions constitute a rare benign type of pathology with a non-odontogenic lineage that 
affect the craniofacial area. According to Waldrom’s classification, these lesions are divided into: fibrous dysplasia 
(FD), cemento-ossifying fibroma (COF) and desmoplastic fibroma (DF).
Material and Methods: A retrospective study was performed on patients diagnosed with fibro-osseous lesions of 
the craniofacial area at the Hospital Universitario La Fe, Valencia, during 1987-2009. A total of 19 cases were col-
lected: 15 cases compatible with an FD diagnosis, 3 cases with a COF diagnosis and 1 case with a DF diagnosis.
Results: In the differential diagnosis, entities having similar clinical manifestations in the maxillofacial area with 
possible involvement of teeth or manifestations present as an asymptomatic radiolucent image should be ruled out. 
We hereby present the management and development of patients treated in our hospital for fibro-osseous lesions.
Conclusions: Fibro-osseous lesions share many clinical and radiological characteristics in common, with histo-
logical features confirming the nature of the lesion. Management of patients should be individualized and case-
specific, assessing the clinical evolution of each case and taking into account the benign nature and growth 
behavior of this type of tumors.
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Introduction
Fibro-osseous lesions constitute a rare type of pathol-
ogy classified as benign tumors of non-odontogenic 
lineage that affect the craniofacial area. These lesions 
were first described by Lichtenstein (1,2) in 1936, and 
have undergone several changes in terms of classifica-
tion and identification over the years. According to the 
classification proposed by Waldrom (3) in 1993, this 
type of pathology is divided into fibrous dysplasia (FD), 
cemento-ossifying fibroma (COF) and desmoplastic fi-
broma (DF).
These entities differ from each other due to different 
clinical, radiological, and histological characteristics 
that help make a diagnosis (Table 1).  Surgical treatment 
of these lesions is favored due to functional or aesthetic 
reasons derived from the lesion growth. The course of 
treatment should be planned and individualized in each 
case based on the manifestations.
FD COF DF
Age 1st – 2nd decade. 3rd – 4th decade. 1st decade.
Gender No difference. > Female. No difference.
Location Maxilla. Posterior jaw. Posterior jaw.
Clinical 
Symptoms
Mono / polyostotic.
Deformity.
Swelling.
Compression (paresis, deafness, 
nasal obstruction, optic nerve 
compression ...).
Deformity.
Swelling.
Displacement or tooth mobil-
ity.
Slow growth, locally aggressive. 
Possible soft tissue swelling after 
lingual cortical destruction.
X-Ray Poorly defined.
Radiolucent.
Fusiform.
Frosted glasses. Calcified foci.
Well defined.
Radiolucent.
Nodular or spherical.
Uni / multilocular.
Mixed pattern radiolucent / 
radiopaque.
Poorly defined.
Radiolucent.
Uni / multilocular.
Malignant appearance (internal 
cortical destruction, rhizolysis).
Histology Fibrous tissue with new bone 
formed trabeculae partially calci-
fied.
Fibrous stroma cell variability 
and trabecular calcified foci 
(bone) / spheroid (cement).
Rich in collagen stroma and fibro-
blasts groups.
Treatment Expectant.
Bone remodelling.
Resection.
Curettage and bone remodel-
ling.
Resection.
Remodelled and curettage
(if cortical bone not affect).
Resection.
Course 50% recurrence (curettage treat-
ment).
Complete resection is curative.
Rare recurrence (0-20%) even 
with curettage treatment.
High rate of recurrence (incom-
plete curettage).
Table 1. Differential diagnosis between the different entities of fibro-osseous lesions.
(FD: fibrous dysplasia; COF: cemento-ossifying fibroma, DF: desmoplastic fibroma)
In this report, we show our experience in the diagnosis 
and treatment of this type of lesions. Our objective is to 
disclose the different types of fibro-osseous lesions that 
can affect the craniofacial area. We will analyze their 
clinical, radiological, and histological characteristics 
and we will try to understand their nature as well as 
their natural development. Thus, we will try to provide 
a proper management to patients affected by this type of 
pathology on an individual basis.
Material and Methods
A retrospective study was performed on patients diag-
nosed with fibro-osseous lesions of the craniofacial area 
at the Hospital Universitario La Fe, Valencia. The study 
was conducted from 1987 to 2009. The information col-
lected included age, gender, personal history, associated 
clinical manifestations, accompanying symptoms, radi-
ological and histological information of all cases.
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A total of 19 cases were collected. Of the total number of 
patients, 7 were women and 12 were men. Ages ranged 
between 4 to 73 years old. 9 pediatric patients and 2 
patients aged 65 or more were treated.
The diagnosis was established in 5 cases, as a result of 
a casual finding during routine X-ray studies, without 
evidence of clinical manifestations associated with the 
lesions shown. The patients showed clinical manifesta-
tions associated with the lesions in 14 cases. The most 
common symptom was facial asymmetry, which af-
fected 5 patients. Two patients showed associated facial 
deformation and local swelling and one of the patients 
showed facial deformation and pain. In 3 patients, the 
clinical manifestations included local facial tumors: one 
patient showed a local tumor and associated dental in-
clusion, another patient showed dental inclusion associ-
ated with local swelling, and the third patient showed 
only dental inclusions. In 2 of the cases studied, there 
was a history of previous surgical procedures to treat 
the same pathology; 2 surgeries in one case and 7 in 
the other. One of the cases presented a history of post-
traumatic osteomyelitis of the mandible that had been 
treated in 2 previous occasions, which lead to the ac-
cidental discovery of FD.
Lesions were most frequently found in the mandibular 
area in 11 of the patients (Figs. 1,2), in the maxillary area 
Fig. 1. Patient nº15. 26 years evolution mandibular FD. No significant 
clinical growth, stable and asymptomatic till date.
Fig. 2. Patient nº 4, mandibular FD diagnosed by an incidental find-
ing in a radiological study, clinically asymptomatic.
Fig. 3. Patient nº 19. Right malar COF lesion that required surgical 
resection.
in 4 of the patients, in the malar area in 2 of the patients 
(Fig. 3), with one patient presenting involvement of the pa-
rietal area. One of the patients showed conjoint mandibular 
and maxillary involvement. One case showed a polyostotic 
involvement which included the mandibular area and the 
long bones of the upper and lower limbs, with no evidence 
of endocrine or skin pigmentation alterations.
In all cases, imaging techniques such as orthopantom-
ography (OPG) and computed tomography (CT), were 
used for the study of lesions. As a complementary test, 
a bone scan was performed in 5 of the cases, with nega-
tive results in each.
An invasive surgery consisting of an incisional biopsy 
of the lesion was performed in all patients to obtain a 
histological diagnosis. All procedures were carried out 
under general anesthesia. 
Results
The management of these clinical cases is summarized 
in table 2. In all cases subjected to surgery, tissue sam-
ples were collected and sent for histological assessment. 
Fifteen cases had a diagnosis compatible with FD, 3 
were compatible with a COF diagnosis and 1 case was 
compatible with a DF diagnosis.
In 7 of the cases diagnosed with FD, an expectant at-
titude was maintained. Once the histological confirma-
tion was obtained from the 6 cases diagnosed with FD 
and from the one diagnosed with COF, a wide bone re-
modeling was performed on the lesion for aesthetic pur-
poses. Five patients (2 with FD, 2 with COF and 1 with 
DF) were subjected to a more aggressive surgery, which 
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Patient Age Gender Personal re-
cords
Location Clinical Symp-
toms
AP TT Nº/T Recu-
rrence
nº 1 37 F - Malar Deformity. 
Swelling.
FD BR No
nº 2 23 M 2 previous 
surgeries.
Jaw Deformity. 
Facial pain.
FD BR 1 / 15 years
nº 3 20 F - Jaw Deformity. FD Biopsy Stable
nº 4 26 M - Jaw No. FD Biopsy Stable
nº 5 65 F 7 previous 
surgeries.
Maxilla
Jaw
Recurrent tu-
mor.
FD BR Resec-
tion
1 /  4 years
nº 6 9 M - Maxilla Swelling.
56 included.
FD Biopsy Stable
nº 7 24 M posttraumatic 
osteomyelitis
Jaw No. FD BR 1 / 1 year
nº 8 11 M - Jaw 85 included. FD BR No
nº 9 11 M - Maxilla No. FD Biopsy Stable
nº 10 9 M - Parietal No. FD Biopsy Stable
nº 11 10 M - Jaw No. FD BR No
nº 12 9 M Poliostotic Jaw Swelling. FD Biopsy Malocclusion
nº 13 4 F Epilepsy,
Tuberous scle-
rosis.
Maxilla Swelling. Tooth 
inclusions.
FD BR
Resection
2 / 4 y 5 years
nº 14 55 M - Jaw Deformity.
Swelling.
FD BR No
nº 15 54 F - Jaw Deformity. FD Biopsy Stable
nº 16 73 F Paget disease Jaw Deformity. COF BR 1 / 3 years
nº 17 10 M - Maxilla Deformity. COF Resection No
nº 18 17 F - Malar Deformity. COF Resection No
nº 19 7 M - Jaw Tumor. DF Resection No
Table 2. Presentation of the cases.
(nº: number, F: female, M: male, FD: fibrous dysplasia; COF: cemento-ossifying fibroma; DF: desmoplastic fibroma, AP: pathology, TT: Treatment, 
No/ T Recurrence: numbers and time of recurrence; BR: bone remodeling).
consisted in the total resection of the lesion. One of the 
patients with DF needed a mandibular reconstruction 
with a costochondral graft. In one case of FD, an os-
teoconductive material was used to regenerate the bone 
area being treated.
All cases were followed up with clinical controls per-
formed at 1 month, 3 months, and 6 months after the 
surgery, and an X-ray control was performed six months 
after the operation. 
The patients, who were maintained in an expectant at-
titude, showed a stable condition during the follow-ups, 
without evidence of any clinically significant change 
in the lesions. There was an exceptional case showing 
growth of the mandibular lesion with clinical repercus-
sion exhibited as occlusal alteration which subsequently 
required a mandibular bone remodeling.
The post-operative relapse rate in patients with FD was 
50%. Of the patients diagnosed with COF, one present-
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ed a lesion relapse three years after the surgery, which 
required a new and larger bone remodeling.
Two cases presented surgery-related complications; 
one case developed an infection in the treatment area 
and the other one showed osteonecrosis signs which re-
quired an additional procedure involving curettage and 
bone remodeling. 
No malignant transformation from the lesions was ob-
served in any of the cases submitted up to the beginning 
of the study.
Discussion
Although there are persistent differences in terms of 
classification and diagnosis of fibro-osseous lesions in 
the craniofacial area, there is consensus on the com-
mon characteristic of these lesions.  All of them show 
the replacement of normal bone tissue with fibroblast 
and collagen fiber tissue, with varying quantities of 
mineralized substances. This investigation is based on 
the fibro-osseous lesion classification proposed by Wal-
drom (3) in 1993, who classified them in different enti-
ties, namely: fibrous dysplasia (FD), cemento-ossifying 
fibroma (COF) and desmoplastic fibroma (DF). 
FD is considered a benign progressive entity of unknown 
etiology. It is claimed to have originated as a disruption 
of the osteogenetic function of osteoblasts that lose their 
ability to fully differentiate themselves, which impairs 
bone growth in favor of osteofibrous proliferation. It has 
been suggested that somatic mutation of the GS-α at os-
teoblastic cells cause FD in its different forms. It can 
be clinically manifested in monostotic form with the 
involvement of a single bone (70%), in polyostotic form 
with involvement of more than one bone (30%) or in the 
context of the McCune Albright Syndrome, with associ-
ated skin hyperpigmentation and endocrine disorders, 
such as precocious puberty and/or hyperthyroidism (4). 
FD affecting multiple adjacent bones in the craniofa-
cial area is considered monostotic. Of the 15 patients 
studied with FD, only one of them presented polyostotic 
involvement; associated FD lesions were found in both 
humeri, and in the left femur and tibia, without skin 
lesions or endocrine alterations.  The entity is mainly 
manifested in the first and second decades of life, with 
women being primarily affected, and the jaw being the 
preferred site. At the time of the diagnosis, 11 of the pa-
tients were within this age range, while 4 patients were 
older. In this study, the rear portion of the jaw was the 
most frequent site, with men being more affected (2:1). 
Clinically, it manifests as a painless swelling of the 
affected bones, and may produce aesthetically visible 
deformities and symptoms related to vascular or nerve 
compression such as narrowing of the optic canal. None 
of the patients showed clinical manifestations related 
to compression or compromise of structures, the most 
frequently associated symptoms being asymmetrical 
facial deformity and site swelling. Typically, lesions al-
ternate periods of quiescence with periods of activity 
in which the patient develops swelling, discomfort, and 
increased puffiness; lesions appear as hot spots on the 
scan, and can simulate osteomyelitis episodes or a low-
grade sarcoma. In the latter case, the determination of 
the cell mutation of the GS-α is useful to confirm the 
diagnosis of FD (5). Stabilization of the lesions in late 
puberty or early adulthood is common, although there 
are some cases reported at a later stage. Even though 
it is considered a benign entity, there have been cases 
of sarcomatous degeneration, usually associated with 
the use of radiotherapy treatments, although there are 
cases of spontaneous malignant transformation (6). Ra-
diological images may vary depending on the degree of 
bone present in the lesion. Lesions usually appear as ill-
defined, unilocular or multilocular radiolucent lesions 
with radiopacities on the inside due to the content of 
bone trabeculae. They may also occur as lesions creat-
ing an image of frosted glass. Larger lesions can cause 
cortical thinning and remodeling, although they can 
rarely cause a breakdown. Rhizolysis of erupted teeth 
is a rare finding in this kind of lesions. Histologically, 
they are characterized by fibrous tissue in which newly 
formed bone trabeculae, potentially partially calcified, 
is found. In general, treatment is symptomatic; diag-
nostic biopsies are often the only procedures needed. In 
case of clinical manifestations, surgical treatment can 
range from total resection to curettage of the lesion (7). 
While most cases achieve a complete cure with the first 
measure, less aggressive treatments may show up to a 
50% of relapses. This type of interventions should pref-
erably be performed during periods of quiescence, since 
these lesions have a greater vascular component and are 
more likely to bleed in periods of activity. Six patients 
of the study were subjected to bone remodeling and 2 
were subjected to a complete resection. The post-oper-
ative relapse rate in patients with FD was 4/8 (50%.) 
One patient needed to undergo up to 4 more surgeries. 
In some patients, the time of lesion relapse ranged from 
1 year to 15 years.
COF is considered a benign neoplasm that affects the 
maxillofacial area, manifesting as an intraosseous or 
subperiosteal mass. It has unknown etiology and it is 
typically linked to inflammatory processes, extractions 
and traumatic backgrounds. These tumors affect mainly 
the female sex and they usually occur in the third and 
fourth decades of life. The most common sites are the 
maxillary teeth areas, primarily the mandibular premo-
lar area (70-80%) and the mandibular ramus. Regard-
ing to the gender of the patients diagnosed with COF, 
2 were women and 1 was a man. Two of them were in 
their second decade of life at the time of the diagnosis, 
while the other was 73 years old. The site was different 
in all cases, affecting the left malar area in one case, 
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the rear portion of the mandibular area in another, and 
the front portion of the upper maxilla in the third case. 
COF manifests clinically as a slowly growing, painless 
mass that can result in deformity and facial asymmetry, 
as it happened in the 3 cases shown. Since it is related 
to dental roots, it can cause early tooth mobility. Unlike 
DF, the lesion often appears as a well-defined image in 
X-rays. In the early stages, the lesion presents itself as 
radiolucent areas in which bone densities appear as the 
lesion matures, transforming the image into unilocular 
or multilocular masses of radiopaque tissue surrounded 
by a halo of less ossified tissue. Rhizolysis and displace-
ment of affected teeth (8) can be observed. Histologi-
cally, lesions present a relatively avascular fibrous stro-
ma consisting of fusiform cells intermingled with bone 
trabeculae and spheroidal calcifications that resemble 
cement. Some authors relate the quantity of existing ce-
ment with the degree of growth and aggressiveness of 
the COF (9). While the growth of FD tends to stop at a 
certain age, COF continues to develop until its resection. 
Treatment is by means of surgical enucleation of the le-
sions and curettage of the bone bed. Relapses are rare 
(0-28%), being more frequent when a simple curettage 
of the lesion is performed. There is a variant of COF, 
called active juvenile ossifying fibroma, which affects 
patients aged 5-15 and has a more aggressive behavior 
with a tendency to erode surrounding bones. Despite its 
more aggressive behavior, more mutilating surgeries to 
treat COF are not necessary (10, 11). 
DF is a benign, slow-growing and locally aggressive en-
tity. Its etiology is unknown. Hypotheses of its origins 
include genetic, traumatic and endocrine factors. Any 
bone can be affected; however, the jaw is most com-
monly involved within the maxillofacial area (40% pre-
ferred site for primary FD), where it may extend to soft 
tissues due to breakage of the lingual cortex. 
It usually appears in the first decade of life, without pre-
dilection for either sex.
Clinically, it is manifested by inflammation of the af-
fected area, and can trigger trismus by involvement of 
the masticatory area. Radiologically, it appears as an ill-
defined, unilocular or multilocular radiolucent mass that 
may cause cortical breaks and root resorption. Histologi-
cally, it presents a hypocellular, collagen-rich stroma with 
groups of fibroblasts inside without any osteoid material. 
Treatment of this entity involves broad and aggressive 
en bloc resections of the affected area. Relapses are rare 
with this type of therapy (12). In reference to the patient 
diagnosed with DF, once the histological nature of the 
lesion was known, we decided to perform a complete re-
section of the lesion located in the rear portion of the left 
jaw, and rebuilt it with a costochondral graft. The patient 
has not relapsed up to this date.
Other entities that may manifest clinically as tumors in 
the maxillofacial area, with or without affectation to the 
neighboring teeth and appearing as radiolucent images 
in imaging tests (13-15) should be included in the dif-
ferential diagnosis of fibro-osseous lesions. Some ex-
amples are central giant-cell granuloma, brown tumor 
of  hyperparathyroidism, cherubism, aneurysmal bone 
cyst, intraosseous vascular malformations, Langerhans 
cell histiocytosis, non-odontogenic cysts (globulomaxi-
lar cyst, nasolabial cyst, central mandibular cyst, na-
sopalatine duct cyst) and neurogenic tumors (Schwan-
noma, neurofibroma and traumatic neuroma). In many 
cases, these entities can share clinical and radiological 
characteristics, with histological studies confirming the 
nature of these lesions.
The different types of fibro-osseous lesions share a com-
mon feature, which is the replacement of normal bone 
tissue by fibrous collagen tissue with variable content of 
mineral substances.  The clinical and radiological char-
acteristics will help with the diagnosis and therapeutic 
orientation of patients affected by this pathology, with the 
histological characteristics confirming the nature of the 
lesion (16, 17). Management of patients suffering from 
fibro-osseous lesions should be individualized and case-
specific, assessing the clinical evolution of each case and 
taking into account the benign nature and growth behav-
ior of these tumors (18-20). According to our experience, 
we consider it appropriate to maintain an expectant at-
titude toward FD lesions that do not have significantly 
clinical or aesthetic impacts. Aggressive surgical pro-
cedures should be reserved for relapse cases or cases in 
which lesion growth compromises adjacent structures. 
We consider that, for entities as COF or DF, more ag-
gressive procedures should be planned, namely full 
enucleations or extensive resections, due to the progres-
sive nature of the tumor in order to prevent relapses and 
potential further mutilating procedures.
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